Upcoming events
3rd Biophysics for Drug Discovery Summit 2026
In person
ZoBio will attend the 3rd Biophysics for Drug Discovery Summit 2026 in Boston, a unique, industry-focused forum dedicated exclusively to biophysics. Through case studies, panel discussions, and interactive exchanges, the summit highlights how emerging biophysical technologies are shaping predictive pipelines and accelerating drug discovery.

Marta will share selected case studies demonstrating how biophysical approaches can tackle diverse discovery challenges, from fragment-based screening for molecular glues, to profiling covalent compounds and antibody–antigen interactions, and generating structural models when X-ray crystallography reaches its limits.
If you’re attending, come by our poster to discuss how biophysics can support your discovery challenges. We would be happy to connect!
Past events
Therapeutic Frontiers in Medicine, Mechanisms and Modalities
In person
ZoBio was attending TFMED 2026, a four-day transdisciplinary conference dedicated to next-generation therapeutic modalities, including molecular glues, PROTACs, nucleic acid-based therapies, and cell-based approaches.
The meeting brought together researchers, clinicians, and industry experts, offering in-depth scientific sessions, direct interaction with leading specialists, and valuable opportunities for networking and collaboration, with a strong focus on early-career scientists.
Anna Belorusova presented a flash talk and poster titled: “SPR Workflows for Molecular Glue Hit Discovery.”
In her presentation, she highlighted how ZoBio supports molecular glue discovery through dedicated Surface Plasmon Resonance (SPR) workflows, complemented by a suite of orthogonal biophysical techniques. This integrated platform enables direct assessment of protein–protein interactions, supports fragment screening and validation, and provides insights into the likelihood of identifying molecular glues for specific target pairs.
By combining multiple biophysical approaches, we deliver robust characterization and mechanistic understanding of hits, helping to de-risk early-stage discovery and accelerate progress toward challenging targets
SMR Meeting: Molecular Glues
In person
Molecular glues and targeted protein degraders are revolutionizing the field of drug discovery, offering promising solutions for a range of diseases, including cancer, infectious, inflammatory, and neurodegenerative diseases. These innovative therapies are particularly beneficial for targeting previously “undruggable” pathogenic proteins. The recent emergence of the ‘molecular glue’ class of protein degraders is paving the way for novel treatments aimed at addressing critical unmet medical needs.
In light of the excitement surrounding this breakthrough, the Society for Medicines Research was organizing a one-day meeting at the GSK Campus in Stevenage, UK, focused on the theme of Molecular Glues. Esteemed speakers from both academia and industry presented the latest advances in the field. Presentations covered a variety of topics, including the discovery of molecular glues, their therapeutic applications, and the cell biology that supports the molecular glue concept.
ZoBio was excited to attend the meeting for the second time. Pim de Vink, our Scientist, presented a lecture titled “Cooperativity: How to Discover Molecular Glues de Novo using Biophysics”, which was very well received.
32nd Protein Structure Determination in Industry meeting
In person
Starting from Sunday, November 10th, the ZoBio team participated in the 32nd Protein Structure Determination in Industry meeting, which was held at the Novotel Paris Centre Tour Eiffel in Paris, France. This year’s meeting was organized jointly by SERVIER and Synchrotron SOLEIL, with support from Hg3 Conferences.
The scientific talks focused on the following major themes:
- Synergy of structural and computational approaches
- Structural biology across modalities
- Beyond purified protein
- Integration of data across techniques
Our scientist, Inês Justo, presented a poster titled Tailor-made Structural Biology at ZoBio, highlighting various studies we have conducted across our Structural Biology platforms.